ArticleFrontiers in psychiatry2026
Serum prealbumin at admission is associated with post-stroke depression at 3 months in patients with spontaneous intracerebral hemorrhage.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-stroke depression (PSD) represents a frequent neuropsychiatric condition in patients with spontaneous intracerebral hemorrhage (sICH) and is associated with impaired functional rehabilitation and diminished quality of life. Clarifying biological factors associated with subsequent PSD may improve the understanding of psychological vulnerability after sICH. Serum prealbumin, a negative acute-phase protein that may reflect acute inflammatory and nutritional-metabolic status, has been associated with adverse stroke outcomes, but its relationship with PSD remains unclear. This study aimed to investigate the association between serum prealbumin at admission and PSD at 3 months post-stroke. Methods: A retrospective cohort study was conducted on 446 patients with sICH. Serum prealbumin at admission was defined as the first available measurement obtained within 48 hours after hospital admission. PSD was defined as a diagnosis of depression at 3 months post-stroke, based on the Results: In total, 159 patients (35.7%) were diagnosed with PSD. Serum prealbumin levels were reduced in patients with PSD compared with those without PSD (223.7 ± 52.8 vs. 243.4 ± 53.6 mg/L, Conclusions: Lower admission serum prealbumin was independently associated with higher odds of PSD at 3 months among patients with sICH who completed follow-up assessment. Serum prealbumin may represent a nonspecific peripheral marker reflecting acute inflammatory and nutritional-metabolic status after sICH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.